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First-Trimester 3-Dimensional Power
Doppler Placental Vascularization Indices
From the Whole Placenta Versus the 
Placental Bed to Predict Preeclampsia
Does Pregnancy-Associated Plasma Protein A or Uterine
Artery Doppler Sonography Help?
reeclampsia affects approximately 5% to 8% of pregnancies
in the United States and is a leading cause of both maternal
and perinatal morbidity and mortality, especially in severe
forms, which often require premature delivery.1 Although maternal
characteristics and the pregnancy history can be helpful for identi-
fying patients at high risk, there is still no reliable test to predict
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AUC, area under the curve; BMI, body mass
index; FI, flow index; MoM, multiple of the
median; PAPP-A, pregnancy-associated
plasma protein A; 3D, 3-dimensional; VFI,
vascularization-flow index; VI, vasculariza-
tion index
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Objectives—The purpose of this study was to compare the use of vascular indices
derived from the whole placenta to those from the placental bed only for predicting
preeclampsia and to determine whether the addition of pregnancy-associated plasma
protein A (PAPP-A) and mean uterine artery Doppler values improves prediction. 
Methods—We conducted a secondary analysis of a prospective cohort of women with
singletons between 11 and 14 weeks’ gestation undergoing sonography for aneuploidy
screening. Placental vascularization indices from the whole placenta versus the placen-
tal bed were combined with first-trimester maternal serum PAPP-A levels, mean
uterine artery Doppler values, or the combination of both to predict the development
of preeclampsia or early preeclampsia (delivery <34 weeks). The predictive ability of
each vascular index was calculated by using areas under receiver operating characteristic
curves. The sensitivity of the model for predicting preeclampsia and early preeclampsia
at fixed false-positive rates of 10% and 20% was calculated. 
Results—Of 570 women, 48 (8.4%) had preeclampsia, and 10 (1.7%) had early
preeclampsia. The area under the curve and sensitivity values for the prediction of
preeclampsia or early preeclampsia were not different when evaluating the whole pla-
centa versus the placental bed. Additionally, there was no significant improvement when
adding PAPP-A, uterine artery Doppler values, or both. The variables in the model were
more sensitive for the prediction of early preeclampsia than preeclampsia. 
Conclusions—Although placental bed vascular indices are modestly predictive of
preeclampsia, the addition of PAPP-A and uterine artery Doppler values to vascular-
ization indices in the whole placenta or the placental bed did not significantly improve
their predictive ability. 
Key Words—first trimester; obstetric ultrasound; preeclampsia; 3-dimensional placental
vascularization
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which patients will ultimately develop preeclampsia. Many
recent studies have evaluated serum or sonographic mark-
ers to further differentiate those at high risk with conflict-
ing results.2 Serum markers, including first-trimester
placental protein 13, pregnancy-associated plasma protein
A (PAPP-A), free β-human chorionic gonadotropin, and
uterine artery Doppler values, have been studied for the
prediction of poor pregnancy outcomes with some prom-
ising results.3–9
Three-dimensional (3D) power Doppler sonography
has been used in various areas of obstetrics and gynecol-
ogy to evaluate vascular indices in areas of interest. This
technique serves as a noninvasive method to evaluate the
placenta and has become a method of investigation to eval-
uate placental blood flow as early as the first trimester.
Given the central role of the placenta in the pathogenesis
of preeclampsia, specifically the abnormal invasion of tro-
phoblastic cells and remodeling of maternal spiral arteries,
there is a biologically plausible mechanism for evaluating
the vascular indices of the placenta to identify pregnancies
at risk for preeclampsia.10,11 The indices of interest have been
well described and include the vascularization index (VI),
flow index (FI), and vascularization-flow index (VFI).12
Previous studies by our group and others have shown
that placental vascularization indices derived from the whole
placenta are lower in pregnancies that eventually develop
preeclampsia.13–15 However, the discriminatory ability of
these indices alone for predicting preeclampsia is modest.
A recent study suggests that these indices were superior at
predicting preeclampsia when obtained from the placental
bed only.9 The findings from that study have yet to be
validated by other investigators.
The purpose of this study was to compare the use of
vascular indices derived from the whole placenta to those
from the placental bed only for predicting preeclampsia
and to determine whether the addition of PAPP-A and
mean uterine artery Doppler values improves prediction.
We hypothesized that evaluation of these vascularization
indices at the placental bed may better predict the devel-
opment of preeclampsia compared to the entire placenta. 
Materials and Methods
We conducted a secondary analysis of a prospective cohort
study evaluating the prediction of adverse pregnancy out-
comes. Women were approached to participate at the time
of first-trimester aneuploidy screening in the ultrasound unit
at Washington University between December 2008 and
April 2012. This study was approved by the Institutional
Review Board. Dedicated research nurses enrolled patients
between 11 and 14 weeks’ gestation with singleton preg-
nancies after informed consent was obtained. Patients with
fetal aneuploidy or anomalies identified on sonography
were excluded from the study.
At the first sonographic examination, gestational age
was calculated from the last menstrual period and confirmed
by crown-rump length measurements. Three-dimensional
scans were performed by experienced obstetric sonogra-
phers using Voluson 730 Expert ultrasound machines (GE
Healthcare, Milwaukee, WI) equipped with 4–8-MHz
transducers and an advanced software package capable of
calculating the specific vascularization indices described
above. The same preestablished instrument power settings
were used in all cases (angio mode, cent; smooth, 4/5; fre-
quency, low; quality, 16; density, 6; enhance, 16; balance,
GO150; filter, 2; actual power, 2 dB; and pulse repetition
frequency, 0.9). The entire view of the placenta was iden-
tified by 2-dimensional sonography; the volume box was
adjusted to scan the entire placenta, and the sonograms
were stored on a removable hard disk for future analysis.
Evaluation of the whole placenta was performed by using
a 4-dimensional computer software program. This process
involved rotating the image at 30° intervals and outlining
the contour of the placental 6 times. The placental volume
and whole placenta VI, FI, and VFI were then calculated.
To interrogate the placental bed only, the region of inter-
est was traced as follows.9 The caliper was used to trace the
deciduo-myometrial junction with a maximal thickness of
the traced area of 1 cm or less to account for the irregular
shape of each placenta. The placenta was rotated at 30°
intervals, and the contour of the placental bed was outlined
6 times (Figure 1). The placental bed VI, FI, and VFI  were
obtained from 4-dimensional power Doppler histograms.
The reproducibility of obtaining these vascular indices was
previously reported by our group.3
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Figure 1. Sonogram for obtaining placental bed vascularization indices.
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A Doppler examination of the uterine arteries was
performed using transabdominal sonography with color
flow mapping. A midsagittal view of the uterus was
obtained, and the cervical canal was identified. The trans-
ducer was then rotated until the paracervical vessels were
visualized. The uterine artery was isolated, and the pul-
satility index was measured. The mean value was obtained
by averaging the left and right values. An elevated mean
uterine artery Doppler value was defined as a pulsatility
index above the 75th percentile for each gestational age.
Trained research nurses extracted baseline maternal
characteristics, medical and obstetric histories, as well as
details of the current pregnancy and outcomes from the
medical record. They also obtained results of PAPP-A levels,
which were drawn in the first trimester and measured by a
commercial laboratory.  These levels were reported as
multiples of the median (MoMs) adjusted for fetal num-
ber, gestational age, maternal age, maternal weight, diabetes
status, history of pregnancy affected by Down syndrome,
family history of open neural tube defects, and ethnicity.
The primary outcome of this study was to determine
the ability of 3D power Doppler vascularization indices in
the whole placenta compared to those in the placental bed
to predict preeclampsia and early preeclampsia. Secondary
outcomes were to determine whether the addition of
PAPP-A and uterine artery Doppler values would improve
the screening efficiency of the placental indices.
Preeclampsia was defined by using guidelines from the
American College of Obstetricians and Gynecologists1 and
by the criteria proposed by the National High Blood
Pressure Education Program Working Group on High
Blood Pressure in Pregnancy.4 Mild preeclampsia was
defined as blood pressures of 140/90 mm Hg or higher
after 20 weeks’ gestation in women with previously normal
blood pressures and proteinuria of 300 mg of greater in a
24-hour period or at least 1+ on a urine dipstick. Severe
preeclampsia was defined as any of the following criteria in
a patient with preeclampsia: blood pressures of 160/110
or higher on 2 or more occasions at least 6 hours apart
with at least 5 g of proteinuria in a 24-hour period or 3+ on
a urine dipstick on 2 samples randomly taken at least 4
hours apart, elevated liver enzymes, visual disturbances,
headache or other neurologic signs, persistent right upper
quadrant pain or epigastric pain, oliguria with less than 500
mL of urine in a 24-hour period, oligohydramnios, and
fetal growth restriction. Early preeclampsia was defined as
preeclampsia requiring delivery before 34 weeks.
Baseline and delivery characteristics were compared
between patients who developed preeclampsia or early
preeclampsia and those who did not by using a Student t
test for continuous variables and a Pearson χ2 test for cat-
egorical variables. Logistic regression analysis was used to
determine whether the vascularization indices from the
whole placenta and placental bed made a significant
contribution to the prediction of preeclampsia or early
preeclampsia as well as to determine whether the addi-
tion of PAPP-A, uterine artery Doppler values, or both
improved the prediction model. Confounders such as
maternal body mass index (BMI), chronic hypertension,
and African American race were controlled for in the
regression model. The performance of the variables in a
screening paradigm was determined by using receiver
operating characteristic curves. The area under the curve
(AUC) was used to estimate the overall predictive ability
of each model. The AUCs for the screening models were
compared by using nonparametric statistics.16 The sensi-
tivity of the model for predicting preeclampsia and early
preeclampsia at false-positive rates of 10% and 20% was
calculated.
Statistical analysis was performed with Stata version
11.0 software (StataCorp, College Station, TX). P < .05
was considered significant. 
Results
Over the study period, 1200 women met inclusion criteria
and underwent sonographic examinations. We excluded
pregnancies in which placental vascularization indices were
not obtained because they were scanned in a room that
did not have an ultrasound machine equipped with the
proper programming to calculate the indices. Twelve
patients were lost to follow-up. The final study population
included 570 patients with both whole-placenta and
placental bed vascularization indices. There were 48
(8.4%) with preeclampsia, including 10 (1.7%) with early
preeclampsia. Table 1 shows maternal demographic data
and pregnancy outcomes for those women with preeclamp-
sia and early preeclampsia compared to those without.
Women who developed preeclampsia or early preeclamp-
sia were more likely to be African American, have chronic
hypertension, and have higher BMIs than those who had
normal blood pressures. Neonates born to mothers with
preeclampsia or early preeclampsia were more likely to be
of an earlier gestational age and lower birth weight than
those with normal blood pressures.
Three-dimensional power Doppler placental vascu-
larization indices (for both the whole placenta and pla-
cental bed alone) were lower among those patients who
developed preeclampsia or early preeclampsia. Pregnancy-
associated plasma protein A MoM values were lower and
J Ultrasound Med 2015; 34:965–970 967
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mean uterine artery Doppler values were higher in those
who developed preeclampsia and early preeclampsia
(Table 2).
There was no significant difference between the AUC
for the prediction of preeclampsia or early preeclampsia
when comparing vascularization indices from the whole
placenta to the placental bed alone. However, prediction
efficiency was improved for early preeclampsia compared
to preeclampsia (Table 3).
The sensitivity (with fixed false positive rates of 10%
and 20%) for the prediction of early preeclampsia was
greater than that for preeclampsia when looking at the pla-
cental vascularization indices of the placental bed or whole
placenta. There was not a significant increase in sensitivity
when adding PAPP-A, elevated uterine artery Doppler val-
ues, or both (Table 3). 
Discussion
In this study, we confirmed the finding of lower placental
vascularization indices in those pregnancies with preeclamp-
sia and early preeclampsia. The use of placental vasculariza-
tion indices for the prediction of preeclampsia or early
preeclampsia yields modest results and is not significantly
improved with the use of the whole placenta versus the
placental bed. We conclude that evaluation of the placental
bed is not superior to evaluation of the entire placenta; how-
ever, it may become useful when evaluation of the entire pla-
centa is not possible (eg, outside the first trimester). Finally,
even though PAPP-A levels were found to be lower and
mean uterine artery Doppler values were found to be higher
in those pregnancies with preeclampsia, the addition of
these markers did not improve the predictive ability of the
Hannaford et al—Placental Vascularization Indices to Predict Preeclampsia
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Table 1. Maternal Characteristics and Pregnancy Outcomes for Patients With Preeclampsia or Early Preeclampsia Versus No Preeclampsia
No PE PE P Early PE P
Characteristic (n = 512) (n = 48) (PE) (n = 10) (Early PE)
Age, y 31.4 ± 587 30.6 ± 6.1 .33 31.2 ± 6.8 .89
Gravidity 2.7 ± 1.7 3.2 ± 2.0 .22 2.3 ± 1.0 .41
Parity 1.0 ± 1.2 1.2 ± 1.4 .55 0.8 ± 1.1 .50
White race, % 57.0 35.4 <.01 20.0 .02
African American race, % 27.2 56.2 <.01 70.0 <.01
Tobacco use, % 8.2 12.7 .3 10.0 .8
Current BMI, kg/m2 27.6 ± 6.8 32.8 ± 1.4 <.01 32.7 ± 8.0 .03
Chronic hypertension 6.6 41.7 <.01 70.0 <.01
Gestational age at delivery, wk 38.2 ± 3.9 35.7 ± 3.8 <.01 30.2 ± 4.7 <.01
Birth weight, g 3256 ± 713 2572 ± 813 <.01 1430 ± 737 <.01
Data are presented as mean ± SD where applicable. PE indicates preeclampsia.
Table 2. Serum Markers and Placental Vascularization Indices for Patients With Preeclampsia and Early Preeclampsia Versus No Preeclampsia
No PE PE P Early PE P
Parameter (n = 512) (n = 48) (PE) (n = 10) (Early PE)
PAPP-A, MoM 1.29 ± 1.0 0.95 ± 0.47 .02 0.98 ± 0.56 .34
(1.20–1.38) (0.82–1.09) (0.58–1.38)
High mean UAD 0.23 ± 0.42 0.25 ± 0.44 .70 0.4 ± 0.03 .20
(0.19–0.27) (0.13–0.38) (0.03–0.77)
Placental bed VI 51.0 ± 21.0 44.1 ± 19.0 .02 42.8 ± 18.7 .22
(49.2–52.9) (38.6–49.6) (29.5–56.3)
Placental bed FI 51.4 ± 11.0 47.6 ± 9.4 .02 45.8 ± 11.3 .12
(50.4–52.3) (44.8–50.3) (37.8–54.0)
Placental bed VFI 27.8 ± 14.7 21.9 ± 12.0 <.01 20.9 ± 12.1 .14
(26.5–29.1) (18.4–25.4) (12.2–29.5)
VI 17.0 ± 10.2 14.8 ± 7.6 .14 12.4 ± 6.5 .16
(16.1–17.9) (12.6–16.9) (7.8–17.1)
FI 44.4 ± 9.0 42.0 ± 7.8 .06 39.7 ± 9.5 .10
(43.6–45.1) (39.6–44.2) (32.9–46.5)
VFI 7.9 ± 5.6 6.4 ± 3.9 .06 5.4 ± 3.6 .15
(7.5–8.4) (5.2–7.5) (2.8–8.0)
Data are presented as mean ± SD (range). PE indicates preeclampsia; and UAD, uterine artery Doppler.
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placental bed vascularization indices. The ability of
preeclampsia prediction with either PAPP-A or mean uter-
ine artery Doppler values does not appear to be different
from that with placental bed vascularization indices alone.
In a similarly designed study, Hafner et al9 evaluated
placental bed vascularization indices in the first trimester
using 3D power Doppler sonography for the prediction of
preeclampsia, intrauterine growth restriction, and “severe
pregnancy problems,” which were defined as pregnancy-
induced hypertension and preeclampsia plus birth weight
at or below the 10th percentile or delivery at or before 34
weeks. That study included a low-risk population of more
than 4000 women and found that placental bed vascular-
ization performed better than other markers such as 3D
placental volume, PAPP-A, and uterine artery Doppler
values in the first and second trimesters. They found that
the placental bed VI could detect 52% of all preeclampsia
cases and 60% of severe preeclampsia cases. The authors
concluded that the placental bed vascularization indices
are superior to other first-trimester sonographic or bio-
chemical markers and performs as well as second-trimester
uterine artery measurements. They also suggested that pre-
vious studies evaluating vascularization indices in the whole
placenta and placental vascular biopsies yielded poorer
results for the prediction of adverse pregnancy problems
due to decreased vascularity of the placenta in the first
trimester secondary to immature development of fetal
vessels in the placental villi. However, in our study, we did
not find a difference in the predictive values of any of the
vascularization indices for detection of preeclampsia,
whether the whole placenta or, specifically, the placental
bed was examined. Additionally, we did not find an improve-
ment in the predictive ability when serum markers or other
Doppler indices were added.
To our knowledge, a study performing a direct com-
parison between 3D power Doppler vascularization indices
of the whole placenta and the placental bed alone has not
been reported previously. Other strengths of our study
included its prospective design and well-maintained data-
base with a low loss to follow-up and comprehensive
maternal histories and delivery outcomes.
However, our study was not without limitations, par-
ticularly its relatively small sample size. Consequently, we
had only 10 patients with early preeclampsia. Our study
may therefore have been underpowered to address this cat-
egory of preeclampsia. However, the overall incidence of
preeclampsia in our cohort was higher than that reported
by Hafner et al9 in the study evaluating placental bed vas-
cularization noted above. Our small number of patients
with early preeclampsia should be considered when inter-
preting our results, as previous studies have suggested that
first-trimester screening paradigms are better at predicting
early-onset preeclampsia.
Many other investigators are developing models with
various combinations of maternal histories, serum markers,
and other physical parameters to formulate prediction mod-
els for detection of preeclampsia and early preeclampsia.
Crovetto et al17 recently published a nested case-control
study within a cohort of nearly 6000 pregnancies, including
28 cases of early preeclampsia. They looked at maternal
characteristics, including mean arterial pressure, uterine
artery Doppler parameters, and serum markers, including
Table 3. Area Under the Receiver Operating Characteristic Curve Values for the Prediction of Preeclampsia and Early Preeclampsia
Sensitivity, % Sensitivity, %
Parameter PE AUC 10% FPR 20% FPR Early PE AUC 10% FPR 20% FP
Whole placenta VI alone 0.77 (0.69–0.84) 45 55 0.89 (0.78–1.00) 79 79
Placental bed VI alone 0.88 (0.77–0.98) 47 60 0.88 (0.76–0.99) 67 80
Placental bed VI + PAPP-A 0.79 (0.72–0.86) 54 54 0.89 (0.78–0.99) 68 80
Placental bed VI + high mean UAD 0.77 (0.69–0.85) 49 62 0.86 (0.71–1.00) 79 79
Placental bed VI + both 0.79 (0.72–0.86) 54 69 0.88 (0.77–1.00) 67 80
Whole placenta FI alone 0.75 (0.68–0.83) 44 56 0.85 (0.78–1.00) 79 79
Placental bed FI alone 0.76 (0.68–0.84) 44 60 0.85 (0.67–1.00) 67 80
Placental bed FI + PAPP-A 0.78 (0.70–0.85) 48 60 0.88 (0.75–1.00) 67 79
Placental bed FI + high mean UAD 0.76 (0.68–0.84) 45 64 0.82 (0.62–1.00) 79 79
Placental bed FI + both 0.78 (0.70–0.85) 48 59 0.87 (0.74–1.00) 68 80
Whole placenta VFI alone 0.77 (0.69–0.84) 44 57 0.89 (0.77–1.00) 79 79
Placental bed VFI alone 0.77 (0.70–0.85) 47 60 0.88 (0.76–1.00) 67 80
Placental bed VFI + PAPP-A 0.79 (0.73–0.86) 52 60 0.89 (0.79–0.99) 67 80
Placental bed VFI + high mean UAD 0.78 (0.70–0.85) 49 65 0.87 (0.73–1.00) 79 79
Placental bed VFI + both 0.79 (0.72–0.86) 53 59 0.89 (0.78–1.00) 68 80
Data were adjusted for maternal BMI, African American race, and chronic hypertension. Values in parentheses are 95% confidence intervals.
FPR indicates false-positive rate; PE, preeclampsia; and UAD, uterine artery Doppler. P < .05 using nonparametric statistics.
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vascular endothelial growth factor, placental growth factor,
soluble Fms-like tyrosine kinase 1, and soluble endoglin.
They found that for the prediction of early preeclampsia,
significant contributors included a maternal history of
chronic hypertension, a history of preeclampsia, mean
arterial pressure, uterine artery Doppler parameters,
placental growth factor, and soluble Fms-like tyrosine
kinase 1. Models using these predictors achieved detection
rates for early preeclampsia of 77.8% with a false-positive rate
of 5% and 88.9% with a false-positive rate of 10% (AUC,
0.958; 95% confidence interval, 0.920–0.996).17
In a recent review by Poon and Nicolaides,18 the effec-
tiveness of screening for early preeclampsia by specific
maternal risk factors alone or in combination with several
biophysical and biochemical markers was evaluated. They
included PAPP-A, placental growth factor, the uterine
artery pulsatility index, and mean arterial pressure.18 They
reported a detection rate of 93% (95% confidence interval,
89%–96%) for early preeclampsia with a false-positive rate
of 5% and 96% (95% confidence interval, 93%–98%) with
a false-positive rate of 10% when these specific variables
were used in a prediction model.
In conclusion, 3D power Doppler placental indices in
the first trimester may serve a role in the prediction of
preeclampsia. Although our data do not support the idea
that the placental bed is superior to the whole placenta, we
suspect that given our knowledge on the pathophysiologic
characteristics of preeclampsia, evaluation of the placental
bed may provide important insight. The use of these
placental vascularization indices from both the placental
bed and the whole placenta were able to predict early
preeclampsia with greater sensitivity than preeclampsia.
Although associations can be made between PAPP-A,
uterine artery Doppler values, and preeclampsia, the exact
combination of these markers to form the best prediction
model for preeclampsia is yet to be determined. Addition-
ally, larger prospective trials are needed to determine both
the combination of these markers as well as the timing
of their evaluation to best detect the development of
preeclampsia, especially early-onset cases. 
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